Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.16B |
| 2 |
Hershey
HSY
|
+$663M |
| 3 |
Lockheed Martin
LMT
|
+$622M |
| 4 |
Altria Group
MO
|
+$525M |
| 5 |
Pfizer
PFE
|
+$499M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.76B |
| 2 |
Merck
MRK
|
+$2.35B |
| 3 |
Automatic Data Processing
ADP
|
+$1.57B |
| 4 |
Blackstone
BX
|
+$1.38B |
| 5 |
Illinois Tool Works
ITW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.85% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Pitney Bowes
PBI
$2.4B
| $18M | ﹤0.01% |
4,154,353
+95,615
| +2% | +$394K |
|
1677
Banc of California
BANC
$3.03B
| $18M | ﹤0.01% |
1,181,697
+110,558
| +10% | +$1.54M |
|
1678
Navient
NAVI
$789M
| $17.9M | ﹤0.01% |
1,031,101
+21,393
| +2% | +$361K |
|
1679
US Physical Therapy
USPH
$1.2B
| $17.9M | ﹤0.01% |
158,650
+6,551
| +4% | +$654K |
|
1680
iShares Core S&P US Value ETF
IUSV
$27.2B
| $17.9M | ﹤0.01% |
202,807
-15,507
| -7% | -$1.33M |
|
1681
PagerDuty
PD
$816M
| $17.9M | ﹤0.01% |
787,208
-45,740
| -5% | -$1.09M |
|
1682
Calix
CALX
$2.26B
| $17.8M | ﹤0.01% |
536,968
+68,478
| +15% | +$2.55M |
|
1683
Hawkins
HWKN
$2.67B
| $17.8M | ﹤0.01% |
231,745
-27
| -0% | -$1.85K |
|
1684
Coeur Mining
CDE
$15.4B
| $17.8M | ﹤0.01% |
4,713,916
+152,042
| +3% | +$438K |
|
|
AAMI
1685
Acadian Asset Management
AAMI
$3.08B
| $17.8M | ﹤0.01% |
777,617
+36,490
| +5% | +$787K |
|
1686
Oscar Health
OSCR
$9.41B
| $17.8M | ﹤0.01% |
1,193,887
+33,404
| +3% | +$458K |
|
1687
Cohu
COHU
$2.26B
| $17.7M | ﹤0.01% |
531,117
+28,551
| +6% | +$929K |
|
|
REVG
1688
DELISTED
REV Group
REVG
| $17.7M | ﹤0.01% |
800,913
+31,253
| +4% | +$585K |
|
|
LADR
1689
Ladder Capital
LADR
$1.21B
| $17.7M | ﹤0.01% |
1,587,504
+51,305
| +3% | +$564K |
|
1690
Nabors Industries
NBR
$1.27B
| $17.7M | ﹤0.01% |
204,998
+23,385
| +13% | +$1.91M |
|
1691
Rhythm Pharmaceuticals
RYTM
$6.81B
| $17.6M | ﹤0.01% |
406,745
+9,060
| +2% | +$397K |
|
1692
MP Materials
MP
$7.36B
| $17.6M | ﹤0.01% |
1,231,331
+32,980
| +3% | +$522K |
|
1693
Embecta
EMBC
$216M
| $17.6M | ﹤0.01% |
1,326,604
+37,609
| +3% | +$583K |
|
1694
Palomar
PLMR
$3.55B
| $17.5M | ﹤0.01% |
208,743
+6,984
| +3% | +$479K |
|
1695
Sunrun
RUN
$2.34B
| $17.5M | ﹤0.01% |
1,326,432
+94,462
| +8% | +$1.3M |
|
1696
Beazer Homes USA
BZH
$877M
| $17.5M | ﹤0.01% |
532,100
-57,433
| -10% | -$1.78M |
|
1697
TG Therapeutics
TGTX
$7.96B
| $17.4M | ﹤0.01% |
1,145,569
+13,673
| +1% | +$218K |
|
|
AVDX
1698
DELISTED
AvidXchange
AVDX
| $17.2M | ﹤0.01% |
1,310,487
+22,314
| +2% | +$268K |
|
1699
St. Joe Company
JOE
$3.54B
| $17.2M | ﹤0.01% |
297,061
+7,186
| +2% | +$397K |
|
1700
CTS Corp
CTS
$1.83B
| $17.2M | ﹤0.01% |
367,524
+16,033
| +5% | +$703K |
|
Similar funds
Charles Schwab's Q1 2024 Portfolio in Review
As of Q1 2024, Charles Schwab held 3,573 positions worth $433B, up 10% from $394B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.8%. Charles Schwab opened 35 new positions and exited 102, leaving the 3,573-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2024 buy was Schwab Fundamental US Large Company Index ETF: 3,608,604 shares worth $81.1M.
- Charles Schwab added most to Bristol-Myers Squibb in Q1 2024, an estimated $2.16B increase.
- Charles Schwab's biggest Q1 2024 reduction was Broadcom, cutting an estimated $2.76B.
- Charles Schwab fully exited Splunk Inc in Q1 2024, selling an estimated $104M.
- Charles Schwab's ten largest holdings make up 20% of its $433B portfolio in Q1 2024.
- Charles Schwab opened 35 new positions and closed 102 in Q1 2024.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $433B.
Based on Charles Schwab's 13F filing for Q1 2024, filed 9 May 2024.